Complementary medicine in uro-oncology

Abstract

Complementary and alternative medicine (CAM) is widespread in oncology patients with auser rate of approximately 40-50%. An accompanying supportive effect can arise through improved adherence, especially in long-term (e.g.endocrine) therapies through active patient involvement. When assessing the evidence on frequently requested methods, there is no high-quality evidence that homeopathy or anthroposophy leads to an improved prognosis. Mistletoe therapy can be considered to improve the quality of life, although the data quality is weak. In prostate cancer, pomegranate has an influence on the prostate-specific antigen. It is currently unclear whether this will also result in an improved prognosis. In contrast the evidence on selenium and vitaminD speaks in favor of integration into the aftercare concept. Supplementation is recommended after the serum level has been determined.